Strategic Acquisition of Control Micro System (CMS)
Acquisition of CMS expands Laser Photonics' reach into the healthcare and pharmaceutical industries, providing a transformative opportunity with potential for significant growth. The pharmaceutical market is expected to grow at nearly 11% annually through 2030.
Improvement in Gross Margin
Gross margin improved by 1,140 basis points to 85.8%, driven by a product mix dominated by CleanTech.
Key Strategic Sales and Partnerships
Secured sales to Acuren and the U.S. Navy, establishing LPC's footprint in the defense sector and expanding its reach in nondestructive testing markets.
Expansion into Asia Pacific Region
Partnership with Brokk Australia to bring LPC's laser technology to industries in Australia, New Zealand, and neighboring markets.